Bridging communities in the field of nanomedicine
Open Access
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 106, 187-196
Abstract
No abstract availableKeywords
Funding Information
- EC JRC Exploratory Research Programme
- EUNCL (654190)
- REFINE (761104)
This publication has 15 references indexed in Scilit:
- Immunotoxicity Testing of Nanomedicinal Products: Possible Pitfalls in Endotoxin DeterminationCurrent Bionanotechnology, 2017
- A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirementsInternational Journal of Nanomedicine, 2016
- Regulatory aspects on nanomedicinesBiochemical and Biophysical Research Communications, 2015
- A method to Quantify the Affinity of Cabazitaxel for PLA-PEG Nanoparticles and Investigate the Influence of the Nano-Assembly Structure on the Drug/Particle AssociationPharmaceutical Research, 2015
- Horizon Scan of Nanomedicinal ProductsNanomedicine, 2015
- Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applicationsJournal of Controlled Release, 2015
- Nanomedicine for Targeted Photothermal Cancer Therapy: Where are We Now?Nanomedicine, 2015
- Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicalsMolecular Immunology, 2014
- Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicinesJournal of Controlled Release, 2013
- Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classicin vitrotestsNanotoxicology, 2013